The Swiss pharmaceutical company, Novartis wants to take over the US biotech company The Medicines Company for 9.7 billion dollars. The had decided to the tips of the two companies unanimously, was informed by Novartis on Sunday evening in Basel.
It had offered $ 85 per Medicines stock. The transaction is expected to be in the first quarter of 2020 to be completed. Will Finance the Acquisition with existing capital, as well as short - and long-term loans.
About the Takeover had already reported a few days ago several media. The US company is developing drugs for cardiovascular disease such as atherosclerosis or hardening of the arteries. (nag/reuters)
Created: 24.11.2019, 21:31 PM